Lv6
2168 积分 2024-01-20 加入
GRADE guidelines 6. Rating the quality of evidence—imprecision
1个月前
已完结
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
4个月前
已完结
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials
4个月前
已关闭
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials
4个月前
已完结
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials
7个月前
已完结
Albiglutide for the treatment of type 2 diabetes mellitus
7个月前
已完结
DTB Select: 7 | July 2014
7个月前
已完结
GLP-1 receptor agonists in the treatment of diabetic non-alcoholic steatohepatitis patients
7个月前
已完结
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
7个月前
已完结
皖公网安备34019202002308
